Atoosa Etezadi

No ORCID on file · 5 papers in corpus · active 2025-2026

Study types

  • review 4
  • article 1

Condition tags

  • endometriosis 3
review 2026
Breaking the endometriosis-stroke axis: lesion-focused hydrogel reprogramming of thromboinflammatory networks
International immunopharmacology ·doi:10.1016/j.intimp.2026.116988

Endometriosis is a chronic, systemic inflammatory disorder characterized by the ectopic implantation of endometrial-like tissue and accompanied by persistent pain and infertility. Beyond the pelvis, accumulating epidemiological evidence ind…

review 2026
Lesion-centric reprogramming: hydrogel-enabled photothermal reset of endometriosis pain
International immunopharmacology ·doi:10.1016/j.intimp.2026.116882

Endometriosis-associated pelvic pain represents a prototypical failure of systemic therapy for a locally organized, neuroinflammatory disease. Persistent pain arises from the convergence of estrogen-driven lesion survival, chronic inflammat…

review 2025
Endometrial regeneration and the role of the extracellular matrix: mechanisms, challenges, and future perspectives
Tissue & cell ·doi:10.1016/j.tice.2025.103074

Endometrial regeneration is a cornerstone of reproductive health, with the extracellular matrix (ECM) playing a pivotal role in tissue repair, regeneration, and fertility restoration. Dysregulated ECM remodeling is at the heart of many debi…

article 2025
Evaluation of Genes and Molecular Pathways Involved in the Switch of Endometriosis to Ovarian Cancer: A Systems Biology Approach
·doi:10.1007/s40944-025-01010-3
review 2025
Lactate-mediated immune suppression and MDSC expansion in endometriosis: Mechanisms and nanoparticle-targeted therapies
Tissue & cell ·doi:10.1016/j.tice.2025.103211

Endometriosis, a chronic gynecological disorder characterized by the ectopic growth of endometrial-like tissue, is associated with severe pelvic pain, infertility, and profound immune dysregulation. Despite advances in hormonal therapy and …